Edition:
India

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.14CNY
12:29pm IST
Change (% chg)

¥0.03 (+0.42%)
Prev Close
¥7.11
Open
¥7.13
Day's High
¥7.16
Day's Low
¥7.06
Volume
6,581,868
Avg. Vol
13,272,452
52-wk High
¥8.00
52-wk Low
¥6.42

Select another date:

Fri, Jan 12 2018

BRIEF-Zhejiang Conba Pharmaceutical issues 156.6 mln shares and raises 1.09 bln yuan

* Says it issued 156.6 million shares and raised 1.09 billion yuan in total, via private placement

BRIEF-Zhejiang Conba Pharmaceutical Sees 2017 Net Profit Up 60-80 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 60-80 PERCENT Y/Y FROM 441.1 MILLION YUAN ($67.65 million) YEAR AGO Source text in Chinese: http://bit.ly/2CRWSBQ Further company coverage: ($1 = 6.5205 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Zhejiang Conba Pharmaceutical two units obtains high-tech enterprise recognition

* Says its two wholly owned Guizhou and Inner Mongolia-based pharma units obtains high-tech enterprise recognition, to enjoy a tax preference of 15 percent for three years from 2017 to 2019

BRIEF-Zhejiang CONBA Pharmaceutical's 9-month net profit up 34.9 pct y/y

* Says 9-month net profit up 34.9 percent y/y at 607.1 million yuan ($91.74 million)

BRIEF-Zhejiang Conba Pharmaceutical gets approval to issue 1.5 bln yuan medium-term notes

* Says it gets approval to issue 1.5 billion yuan ($228.81 million) medium-term notes

BRIEF-Zhejiang Conba Pharmaceutical's H1 net profit up 25.2 pct y/y

* Says H1 net profit up 25.2 percent y/y at 384.6 million yuan ($57.66 million)

BRIEF-Zhejiang CONBA Pharmaceutical unit received approval for drug clinical trials

* Says its controlling unit has been granted approval for drug clinical trials for pirfenidone tablets issued by china food and drug administration

Select another date: